// App-Quantinova.ai

DOP61 : A nationwide cohort study of colectomy rates for ulcerative colitis during the introduction of biologic therapy

Researchers

Presenter

  • G Worley

Principal Investigators

  • A Almoudaris

  • P Bassett

  • J Segal

  • A Akbar

  • P Aylin

  • O Faiz

Medical Centers

  • St Mark's Hospital and Academic Institute, Surgical Epidemiology Trials and Outcome Centre, London, UK

  • Imperial College London, Department of Surgery and Cancer, London, United Kingdom

  • Statsconsultancy Ltd., Buckinghamshire, UK

  • St Marks Hospital & Academic Institute, London, United Kingdom

  • Imperial College London, Dr Foster Unit, Department of Primary Care and Public Health, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • N/A

Drug/Treatment

  • Infliximab

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved